Goddard Glenn 4
4 · Intellia Therapeutics, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Goddard Glenn
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-01+28,628→ 69,213 total - Award
Stock Option (right to buy)
2024-03-01+41,316→ 41,316 totalExercise: $32.66Exp: 2034-02-28→ Common Stock (41,316 underlying)
Footnotes (2)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.